ABCD Autumn Meeting 2003

Event Date: 
Friday, 14 November, 2003

Programme

Thursday 13th November 2003

 

Registration

 

19.00 : Reception

 

20.00 : Dinner

 

Friday 14th November 2003

 

09.00-10.30 : Debate : The NSF strategy for retinal screening will not  prevent blindness from diabetic retinopathy 

Chairman : Dr Bob Ryder

For the motion : Professor Roy Taylor, Newcastle upon Tyne 

Against the motion : Dr Peter Scanlon, Cheltenham 

 

10.30-11.00 : Coffee

 

11.00-12.30 : Clinical Audit presentations

 

11.00-11.30 : Dr Ian Gallen, Wycombe Hospital: 

Prospective audit of the introduction of insulin glargine (Lantus) into clinical practice in type 1 diabetic patients

 

11.30-12.00 : Dr David Levy, Whipps Cross Hospital: Experience with glitazones as triple oral therapy for type 2 diabetes

 

12.00-12.30 : Dr Colin Close, Taunton and Somerset Hospital : Treating hypertension in diabetic nephropathy

 

12.30-13.45 : Lunch

 

13.45-14.30 : Coagulopathy and diabetes - Beyond aspirin - Professor Peter Grant, Leeds

 

14.30-15.15 : HbA1c measurement - What the clinician needs to know - Dr Eric Kirkpatrick, Hull

 

15.15-16.00 : The Diabetes NSF - What is the role of the consultant physician-diabetologist - Dr Sue Roberts , National Clinical Director for Diabetes, Dept of Health

 

16.00 : Tea and conclusion of meeting

Event taxonomy: 
ABCD
Clinical taxonomy: 
Diabetic nephropathy, Diabetic retinopathy and screening, Treatments for diabetes, Type 1 diabetes mellitus, Type 2 diabetes mellitus

Information for HCPs

COVID-19 Information for Healthcare Professionals